A detailed history of Shum Financial Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Shum Financial Group, Inc. holds 5,510 shares of ABBV stock, worth $934,661. This represents 0.93% of its overall portfolio holdings.

Number of Shares
5,510
Holding current value
$934,661
% of portfolio
0.93%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $902,758 - $1.1 Million
5,510 New
5,510 $1.11 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Shum Financial Group, Inc. Portfolio

Follow Shum Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shum Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Shum Financial Group, Inc. with notifications on news.